Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin for reduction of sepsis mortality in preterm neonates
IRCT138710301378N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of immune globulin in neonatal sepsis and neonatal infection, sponsored by Mashhad University of Medical Sciences. Started Jul 2002; status: completed.
02
Drugs
immune globulin
03
Conditions
neonatal sepsisneonatal infection
Beyond the preview
Go deeper on IRCT138710301378N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138710301378N4.